Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2216 of 5804
-
New brain cancer drug shows promise in early trial
Disease control TerminatedThe objective of this pilot study is to evaluate the efficacy of adding S-Gboxin to standard RT/TMZ treatment protocols in patients with glioblastoma multiforme (GBM) or midline glioma (DMG), regardless of their mutation status
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New pill aims to shrink spleen and ease symptoms in hard-to-treat bone marrow cancer
Disease control Recruiting nowThis is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in participants with myelofibrosis (MF).The dose escalation portion utilizes a standard 3+3 design to evaluate two dose levels with an additional dose de-escalation portion to…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Weighted blankets put to the test for ADHD Kids' sleepless nights
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate if a commercially available (retail-grade) weighted blanket can improve sleep in children with Attention Deficit Hyperactivity Disorder (ADHD) and sleep disturbances. 100 children will be enrolled in the study. The location of the…
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Could a common vitamin help fix low blood counts?
Disease control Recruiting nowThis is an open-label, phase 2 study for lower risk MDS and high risk CCUS patients who are transfusion independent. There will be two cohorts enrolled at the same time to measure the effect of nicotinamide riboside and pterostilbene at different doses. The primary goals of the s…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Shock therapy? electrical zaps may help kids with cerebral palsy walk better
Disease control Not yet recruitingto investigate the effect of the reciprocal neuromuscular electrical stimulation on balance and quality of life in hemiparetic children
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Magnetic pulses to the brain may help you sleep better
Symptom relief Not yet recruitingChronic insomnia disorder is a common condition in which people have ongoing difficulty falling asleep, staying asleep, or waking too early. It affects about 10-12% of adults and can lead to daytime problems, stress, and other health issues. Current treatments include talk therap…
Phase: NA • Sponsor: San Francisco Neurology and Sleep Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Fake health news: study reveals how online lies harm chronic patients
Knowledge-focused Recruiting nowA cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior.
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New brain zapping technique could ease Parkinson's symptoms without surgery
Symptom relief Recruiting nowTranscranial temporal interference stimulation (tTIS) is a non-invasive deep brain stimulation method. This study aims to comprehensively explore the efficacy and safety of bilateral subthalamic nucleus (STN) tTIS on motor and non-motor symptoms in patients with Parkinson's disea…
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Reward yourself to drink less: simple trick tested in new trial
Disease control CompletedContinuous levels of hazardous alcohol consumption (i.e., 14 or more units per week) is one of the leading risk factors of ill health and early mortality, contributing to around 9,809 deaths a year in the UK. The aim of the present research is to test the effect of helping people…
Phase: NA • Sponsor: Lancaster University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can teletherapy help veterans with brain injury feel less emotionally numb?
Symptom relief Recruiting nowThe purpose of the study is to test two different training programs to find out which is better at helping people with a concussion or mild TBI (mTBI) improve their emotional health and well-being. Study participation is completely remote and will last approximately 8 months tota…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New device aims to stop leaks after prostate surgery without needles or surgery
Symptom relief ENROLLING_BY_INVITATIONUrinary incontinence is a common complication following prostatectomy and affects a substantial proportion of patients. Despite advances in surgical technique, many patients experience persistent symptoms that negatively impact quality of life. Current management strategies inclu…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New hope for Tough-to-Treat colon cancer? early trial launches
Disease control Recruiting nowTo learn if SAR445877 in combination with FOLFOX6 and bevacizumab can be safely given to patients with advanced MSS CRC.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a common gout pill boost antidepressants?
Symptom relief Not yet recruitingMajor depressive disorder (MDD) is one of the most common psychiatric disorders with serious socioeconomic consequences on daily life and health care costs. Despite the advent of newer antidepressants that target monoamine pathways, nearly 50% of patients have no response to firs…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New heart tool aims to simplify AFib treatment
Disease control Recruiting nowThe main purpose of this study is to investigate the workflow of the clinical use of the pulsed field (PF) ablation system (VARIPULSE catheter and TRUPULSE generator) when used for cardiac ablation with the new VARIPULSE Pro software in participants with persistent atrial fibrill…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Biofeedback training aims to restore sexual health in cervical cancer survivors
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the efficacy of biofeedback-assisted pelvic floor muscle training on radiation-induced sexual dysfunction in cervical cancer survivors following pelvic radiotherapy. Participants will be randomly assigned to receive either biofeed…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Could a cream stop scarring hair loss? small trial begins
Disease control Recruiting nowThis study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or central centrifugal cicatricial alopecia (CCCA) over a 48-week treatment period. Approximately 30 participants will be enr…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a COPD drug ease rheumatoid arthritis?
Disease control Recruiting nowRheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and reduced physical function. Although standard disease-modifying antirheumatic drugs are effective for many patients, some individuals continue to have active disease. The purpose of this …
Phase: PHASE2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can warning labels on cannabis products change how consumers think about risk?
Knowledge-focused Recruiting nowThis discrete choice experiment (DCE) study aims to address gaps in cannabis packaging regulatory research by testing how variations in cannabis packaging and health warning design impact reactions to packaging and intentions about cannabis use. The goal of this work is to identi…
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New heart rehab study tests hybrid approach to boost patient participation
Disease control Recruiting nowCardiac rehabilitation (CR) is an effective evidence-based intervention that improves outcomes in patients with acute coronary syndrome (ACS), but many eligible patients do not complete the program. A hybrid CR intervention that combines telehealth, home-based, and clinic-based c…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to ease chronic pain after breast removal
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the erector spinae block can reduce the incidence of chronic pain compared to the paravertebral block in adult patients undergoing total mastectomy. The study includes patients aged 18 to 80 years scheduled for mastectomy, with or wi…
Phase: NA • Sponsor: American University of Beirut Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC